The Department of Defense (DoD) is offering the Spinal Cord Injury Investigator-Initiated Research Award to support innovative studies aimed at significantly advancing Spinal Cord Injury (SCI) research and patient care. This grant is for projects demonstrating clear military relevance, addressing the healthcare needs of the Armed Forces, their families, and U.S. veterans. Research may cover basic to translational phases, including preclinical studies, requiring strong preliminary data from the research team. This mechanism specifically excludes clinical trials. The DoD strongly encourages collaboration with military researchers, clinicians, and interdisciplinary scientists. Qualified collaborators must contribute significantly, requiring a minimum 10% effort. All proposed research involving human subjects or biological substances will undergo extensive DoD regulatory review, necessitating ample time for approval.
Opportunity ID: 55316
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-10-SCIRP-IIRA |
Funding Opportunity Title: | DoD Spinal Cord Injury Investigator-Initiated Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jun 18, 2010 |
Last Updated Date: | – |
Original Closing Date for Applications: | Dec 01, 2010 |
Current Closing Date for Applications: | Dec 01, 2010 |
Archive Date: | Dec 31, 2010 |
Estimated Total Program Funding: | $11,250,000 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The SCIRP Investigator-Initiated Research Award (IIRA) mechanism was first offered in FY09. Since then, 70 Investigator-Initiated Research Award applications have been received, and 13 have been recommended for funding. The IIRA is intended to support studies that have the potential to make an important contribution to SCI research and/or patient care. Projects should be innovative, address an Area of Encouragement, and be applicable to the health care needs of the Armed Forces, their family members, and/or the U.S. veteran population. All applications must specifically and clearly address the military relevance of the proposed research. Collaboration with military researchers and clinicians is encouraged. Research projects may focus on any phase of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial. Observations that drive a research idea may be derived from laboratory discovery, population-based studies, a clinicians first-hand knowledge of patients, or anecdotal data. Proposals must include preliminary and/or published data originating from the PI, research team, or partners that is relevant to the topic area and the proposed project. Clinical trials are not allowed under this mechanism. The SCIRP encourages clinical trials with a focus on rehabilitation through the Clinical Trial Award Rehabilitation (for information about this award mechanism, see http://cdmrp.army.mil). Principal Investigators (PIs) wishing to apply for funding for a clinical trial focused on Rehabilitative Medicine should utilize this mechanism. A clinical trial is defined as a prospective accrual of patients where an intervention is tested on a human subject for a measurable outcome for safety and/or efficacy. Clinical trials require informed consent on the subject, and may include identifiable information. Use of Human Subjects and Human Biological Substances: All DOD-funded research involving human subjects and human biological substances must be reviewed and approved by the USAMRMC Office of Research Protections (ORP), Human Research Protection Office (HRPO), in addition to local IRBs. The HRPO is mandated to comply with specific laws and directives governing all research involving human subjects that is conducted or supported by the DOD. These laws and directives are rigorous and detailed, and will require information in addition to that supplied to the local review board. Allow a minimum of 6 months for regulatory review and approval processes for studies involving human subjects. Optional Qualified Collaborator(s): The FY10 SCIRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the SCI field are also strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding. To utilize the Optional Qualified Collaborator: 1) The PI must submit a Statement of Collaboration that clearly identifies the collaborating investigator and addresses how each of the criteria below are met, and 2) The collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear that the success of the project depends on the unique skills and contributions of each partner. Optional Qualified Collaborator Criteria: The collaborator(s) must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. ○ A proposed project in which the collaborator(s) merely supplies tissue samples or access to patients will not meet the intent and will not be qualified for the higher level of funding. Either the PI or the collaborator(s) must have SCI research experience as demonstrated through publications and/or funding history. The collaborator(s) must be at or above the level of Assistant Professor (or equivalent). At least a 10% level of effort is required of the collaborator(s). Contribution of the collaborator should be reflected in the applications budget. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-619-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 55316 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 55316 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Folder 55316 Full Announcement-1 -> scirp_fy10 iira pa_final.pdf
Packages
Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-619-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00019317 | Jun 18, 2010 | Dec 01, 2010 | View |
Package 1
Mandatory forms
55316 RR_SF424_1_2-1.2.pdf
55316 PerformanceSite_1_4-1.4.pdf
55316 RR_KeyPersonExpanded_1_2-1.2.pdf